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During our studies on the progenitor or stem cell responsible for humoral immunity 
(1, 2) it became evident that the organ distribution of the stem cell does not parallel 
the distribution of immunocompetent cells. In the present work, we have studied the 
occurrence of  immunocompetent cells  in different  chicken  tissues  during different 
stages of ontogeny. For this purpose, immunoeompetent cells for humoral immunity 
are considered  those cells which react with antigens and produce antibodies, without 
defining how many cell types are involved. 
Previously, different methods have been applied to studies of the immunocompetent 
cells in avian tissues.  Studies by several investigators (3-5) have demonstrated that 
spleen cells of immunized adult and young chickens adhere and lyse sheep red blood 
cells (SRBC), ~  whereas  cells taken from bursa of Fabricius are inactive in this respect. 
The earliest studies on antibody response by transferred cells suffered from allogeneic 
rejection (6,  7).  To avoid such  rejection, newly hatched  and embryonic recipients 
have been used  to  demonstrate antibody production by spleen, bone marrow,  and 
thymus cells from immunized and normal donors (8-16). In these models, however, 
the  transplanted  cells  induced  a  graft-vs.-host  reaction  in  the  young  recipients. 
Graft-vs.-host reactions were also obtained when hormonally bursectomized recipients 
were used (13, 17). In surgically bursectomized chickens,  bursal transplants, as such 
or in a diffusion chamber, were found to increase antibody synthesis if the chickens 
were stimulated within 3 days after transplantation (18-21). 
The histoincompatibility  reactions can be mostly avoided by having birds isogeneic 
at the B  locus.  Using this model,  Orlans and Rose  (22) showed  that preimmunized 
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cells taken  from  cecal tonsil,  blood,  and  peritoneal  exudate  produced  antibodies  to 
human  serum  albumin  when  transferred  into  adult  chickens.  Gilmour  et  al.  (23) 
transferred bursa cells into newly hatched irradiated chicks and found that these cells 
produced antibodies to Brucella abortus but not to SRB C; when spleen cells were used, 
antibody  response  to  both  Brucella  and  SRBC was  obtained.  Similar findings  with 
bursa  cells were reported  by Weber and  Weidanz  (24)  using 4-wk old irradiated  re- 
cipients treated in ovo with testosterone and cyclophosphamide. After transplantation 
of spleen cells, they could demonstrate a response to SRBC but not to Brucella. 
In  the present  work,  the  occurrence  of imnmnocompetent  cells for humora 1 
immunity has  been studied  in  embryonic liver, yolk sac,  bursa,  bone marrow, 
spleen,  and  thymus.  Cyclophosphamide-treated  immunoincompetent  chicks 
have  been  injected  with  cells from normal  donors  identical  with  recipients  at 
the B  locus. The same period of ontogeny has been considered as in prior studies 
with the bursal stem cell (1, 2). The results obtained reveal a  different distribu- 
tion  of immunocompetent  cells for responses  to  SRBC  and  Brucella.  The  dis- 
tributions  observed  are  compared  with  the  distribution  of  the  stem  cells  for 
humoral immunity, and it becomes evident that the presence of immunocompe- 
tent  cells in  an  organ  does not  indicate  the presence  of stem cells in  the same 
organ  or vice versa. 
Materials  and Methods 
Experimental  Design.--The  major  experiments  on  ontogeny of antibody  production  by 
cells from different organs were carried out by injecting 4-day old cyclophosphamide-treated 
chicks intravenously with lymphoid cells  together with SRBC and Brucdla  abortus. 4  days 
later the chicks were stimulated with the same antigens  intraperitoneally.  For the cellular 
cooperation experiments, only SRBC were used as antigen. Antibody titrations were always 
carried out from samples taken 4 days after the second  stimulation. 
Chlckens.--In  the  experiments  concerning  antibody  response  by  transferred  cells,  the 
recipients and  donors were White Leghorn F1 hybrids homozygous at the major  histoeom- 
patibility locus,  blood type B2B 2. All donors were normal unimmunized chickens.  Cells taken 
from a  specific  organ were pooled before transfer;  at least three donors were used for each 
experiment. In the experiments on graft-vs.-host activity, embryos and chickens  of a White 
Leghorn line, uniformly heterozygous F1 hybrids B2B t a, and embryos of a  random-bred White 
Leghorn line were also used.  Hatching eggs for the lines defined at the B locus were obtained 
from the Basic Research Laboratory,  Hy-Line Poultry Farms  (Johnston, Iowa) and for the 
random-bred line from the Ghostley Hatcheries (Anoka,  Minn.). The specific details for the 
incubation of eggs as well as for the housing and care of the chickens have already been given 
(1). 
Cyclophosphamide  Treatment.  Cyclophosphamide  (Cytoxan;  Mead  Johnson  Labora- 
tories, Evansville, Ind.)  was injected intraperitoneally as freshly prepared  aqueous solution 
2 rag/0.1 cc per chick daily on 4 consecutive days starting on the day of hatching. 
Preparation  and  Injection  of Single Cell Suspensions,  Antibody Titrations,  and  the  Sta- 
tistics.  Methods employed in this investigation have also been described (1). 
Antigenic Stimulation.--In  the experiments  on the ontogeny of antibody production  by 
ceils  from different organs, 0.1  cc of packed  SRBC and 0.1  cc of 1:50  dilution  of Brucella 
abortus  (U.S.  Department  of Agriculture)  were given sirhultaneously  (2  X  10  °  SRBC and 
5 X  108 Brucella organisms per chicken). The antigens were administered intravenously with 818  IMMUNOCOMPETENT CELL  :FOR HUMOI~A.L IMI~LUNITY 
lymphoid cells  1 day after the last cyclophosphamide injection in a  total volume of 0.5  cc. 
4 days later, the same amount of both antigens in 0.5 cc was given intraperitoneally. The same 
schedule was followed in the experiments on cellular cooperation, except that 0.1 cc of packed 
or 20% SRBC were used instead of SRBC and Brucella together. The animals were always 
bled by heart puncture 4  days after the second stimulation. This scheme has been applied 
earlier in mice by Claman et al.  (25-27). 
Assay of Graft-Versus-Host Activity.--Spleen  cells and heparinized (5 units/cc)  heart blood 
taken  from cyclophosphamide-treated and  from normal,  untreated chicks at  various ages 
were injected intravenously into 12-day  old embryos. Spleen cells from several donors were 
pooled before transfer; peripheral blood from each donor was used individually. The eggs were 
opened 7 days later, and spleen indices were determined as usual (28). As donors and recipients, 
a parental-F~ hybrid combination with respect to the B locus was used: BeB 2 line as  donors 
and B2B 15 as recipients. Also, embryos of a random-bred line were used as recipients; they 
were injected with cells taken from B2B 2 and B2B 15 lines. 
TABLE  I 
Antibody Response of Cyclophosphamlde-Treated 4-Day Old Chicks and of Normal,  Untreated 
Chicks at Different Ages 
SRBC  BrucelIa 
Age at first  Treat-  No. of  Mean 4- SB |og~  titer of responders  No. of  Mean :t: SD logs 
stimulation  ment  responders/  responders/  titer of 
total  Direct  Indirect  total  responders 
days 
4  CY  0/65  --  --  0/65  -- 
4  CY  0/47*  --  --  0/42*  -- 
4  None  15/15  3.7  4-  1.7  5.9  4-  1.5  5/15  3.2  4-  1.3 
11  "  10/10  4.9  4-  1.5  7.7  4-  2.0  4/10  3.8  4-  2.2 
18  "  12/12  4.7  4-  0.8  10.7  4-  1.3  10/I2  4.6  4-  1.3 
25  "  10/10  4.8  4-  0.9  9.5  4-  1.9  10/10  6.8  4-  0.9 
32  "  12/12  6.2  4-  1.6  10.1  4-  1.1  12/12  9.2  4-  1.0 
Cyclophosphamide (CY)  was given 2 mg/chick per day on 4 consecutive days beginning 
on the day of hatching. 
Both antigens  (0.1 cc of packed SRBC and 0.1  cc of 1:50 Brueella abortus) were given 
together in 0.5 cc, intravenously 1 day after the final injection with cyclophosphamide, and 
intraperitoneally for the second stimulation 4  days later.  Bleeding was carried out 4  days 
after the second stimulation. 
* These birds were stimulated with either SRBC or Brucella alone. 
RESULTS 
Immunocompetence of Cell Recipients.--To  ascertain that antibody responses 
were due to the function of transferred cells and not to the immune reaction of 
the recipients, humoral and cellular immunocompetence of the hosts was eval- 
uated. 
It  has been previously reported that  chickens treated in  the newly hatched 
period with cyclophosphamide are severely deficient in humoral immunity when 
tested at  the age of a  month or later  (1,  2, 29-31).  Cyclophosphamide-treated 
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TABLE  II 
Graft-Versus-Host  Activity  of  Lymphoid  Cells  Taken  From 
Cyclophosphamlde-Treated  Chickens 
Donors  Recipients 
Strain  Treat-  Age  Number  Cells injected  .P*  ment  Strain  Number  SpleenMean  4-indexsD 
B2B  2  None 
"  CY 
"  None 
"  CY 
"  None 
"  CY 
"  None 
"  CY 
"  None 
"  CY 
tl  None 
"  CY 
"  None 
"  CY 
"  None 
"  CY 
B2B  16  None 
"  CY 
~  None 
"  CY 
"  None 
"  CY 
Controls 
B2B  2  None 
B2B2  None 
B2B  15  None 
days 
5  11  7  X  105 spleen  cells  BeB  15  8  1.36  ±  0.38 
5  11  7  X  105  "  "  5  1.02  4-  0.19 
5  4  0.2 cc blood  6  1.35  4-  0.12) 
5  4  0.2  "  "  "  4  0.97  4-  0.09f  <0"001- 
13  6  7  )<  105 spleen  cells  "  6  2.02  4-  0.27~ 
13  9  7  )< 105  "  "  "  7  1.38  4-  0.29f <0"01 
13  6  7  X  l0 s  spleen  cells  "  7  2.22  ±  0.42~ 
13  9  7  )<  l0 s  "  "  "  7  1.41  4-  0.39f  <0'01- 
13  3  0.2 ec blood  "  5  3.90  4-  0.86~  . 
13  3  0.2  "  "  "  5  2.50 4-  0.53)  <0"0~- 
21  6  7  X  10  s  spleen cells  Random  bred  12  3,33  4-  1.62~ 
21  6  7  X  105  "  "  "  "  12  1.87  4-  0.77] <0"01 
21  6  7  X  106 spleen  cells  "  "  7  3,40 4-  0.78 
21  6  7  X  106  "  "  "  "  13  2,94  4-  1.06 
21  3  0.1  ec blood  "  "  13  5.12  4-  1.29 
21  3  0.1  "  "  "  9  4.37  -4-  1.79 
8  5  7  )<  105 spleen  cells  "  "  10  2.86  4-  0. _27~ 
8  15  7  X  105  ........  12  1.16  -4-  0.31f <°'0°1 
8  5  2  X  106 spleen  cells  "  "  8  3.24  4-  0.71~ 
8  15  2×10s  ........  9  16s4-07¢  <°'°°1 
8  7  0.1  cc blood  "  "  18  4.68  4-  2.2656) 
<0.001 
8  5  0.1  "  "  "  "  26  2.24  4-  1.4 
--  --  None  B2B I5  13  1.01  4-  0.22 
--  --  None  Random  bred  6  0.90 4-  0.26 
5+13  11+6  7Xl0Sor7X10Sdead:~  B2B 15  20  1.004-0.25 
spleen  cells 
21  6  7  X  106 dead  spleen  cells  Random  bred  13  1.00  4-  0.29 
8  5  2  X  106 dead  spleen  cells  "  13  1.00  4-  0.22 
*  Only  values  <0.05  are  given. 
1 hr at 56°C. 
cate  that  cyclophosphamide-induced immunological  unresponsiveness  begins 
immediately after the treatment (Table I). 
Table I shows also the development of antibody responses in intact untreated 
chicks. At the age of 4 days, 15 of 15 birds responded with moderate antibody 
titers to SRBC, whereas only 5 of 15 birds responded to Brucella.  When stimu- 
lated at the age of 25 days, 10 of 10 normal birds produced also Brucella anti- 
bodies. 820  IMMUNOCOMPETENT  CELL  FOR  HUMORAL  IMMUNITY 
Cellular immunocompetence of cyclophosphamide-treated chicks was deter- 
mined by means of the graft-vs.-host reaction. The capacity of spleen cells and 
peripheral  blood  to  induce  splenomegaly in  12-day embryos was  determined 
(Table II). When cells from 5-,  13-, and 21-day B2B 2 donors were injected into 
B2B 1~ embryos, the cyclophosphamide-treated donors were deficient in graft-vs.- 
host activity when compared with normal untreated donors. The difference was 
clearer with  cells  from 5-  and  13-day old donors  than with  cells  from 21-day 
donors. This finding cannot, however, be taken as evidence of absolute recovery 
of immunocompetence by 21  days, since even in the earlier stages use of a too 
large cell dose for testing can obscure the differences between treated and un- 
treated birds. 
It has been demonstrated that graft-vs.-host competence of B2B 2 lymphoid 
cells is less than that of lymphoid cells with other genotypes (32,  33). To deter- 
mine whether  this phenomenon  might have influenced  our results,  8-day old 
BeB *a donors were used to assess the graft-vs.-host activity of cyclophosphamide- 
treated chicks. The results (Table II) confirm those obtained when cells of B=B  2 
donors were used. 
These findings  indicate  that  chickens  treated  in  the newly hatched  period 
with  cyclophosphamide are inferior in  cellular immunity to normal  chicks  of 
the same age. At the age of 4 days (time of lymphoid cell  transfer used in this 
study)  the cyclophosphamide-treated animals are completely immunoincompe- 
tent. These findings also indicate the inferiority in cellular imnmnity up to the 
age of 21 days, and data published by others (29,  34) reveal it also later in life. 
Distribution of Immunocompetent Cells Responsible for Humoral Immunity.-- 
2  X  10  7 lymphoid cells from bursa, bone marrow, spleen, and thvnms from do- 
nors  of different  ages were  injected  intravenously  together  with  SRBC  and 
Brucella abortus into cyclophosphamide-treated 4-day old chicks. A second anti- 
genic stimulation was given intraperitoneally 4 days later. Antibodies to both 
antigens were determined from samples taken 4 days after the  second stimula- 
tion. 
The antibody responses to SRBC  are illustrated  in Fig.  1.  With  increasing 
age of donors, spleen cells are the first to respond to SRBC in 100%  of the re- 
cipients; these cells were taken from 3~}-wk old donors. Thymus and bone mar- 
row  cells  elicit  a  similar  response when  obtained  from  7-  and  12-wk  donors, 
respectively. With all of these three cell types, the number of responding recipi- 
ents increases with the age of donors, and is maintained at 80-100% after reach- 
ing that level. Bursa cells also give an antibody response in an increasing num- 
ber of recipients, reaching a 45 % level at the donor age of 12 wk. Contrary to 
the results with other cells studied, bursa cells do not form antibodies to SRBC 
when taken from 17-wk donors. Direct and indirect hemagglutinin  titers with 
all cell types parallel roughly the number of responding hosts except when cells 
taken from 17-wk donors were used. In such samples a slight reduction,  espe- 
cially in the direct titers, was found when comparison was made with  the re- 
sponse by cells taken from younger animals. PAAVO  TOIVANEN,  AULI  TOIVANEN,  AND  ROBERT  A.  GOOD  821 
The  antibody responses  to  Brucella  are shown  in  Fig.  2.  Bursa  cells, fronl 
chicks aged 3~  wk, are the first to respond in 100% of the recipients. By  12  wk 
of age, spleen and thymus cells also elicit a  similar response. For bone marrow 
cells, such a  response is obtained at 17 wk of age. Agglutinin titers parallel the 
number of responders and rise steadily with the increasing age of donors. Con- 
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FIG. I. Antibody response to SRBC by 2 X  I0  v lymphoid cells injected into cyclophos- 
phamide-treated 4-day old chicks.  SRBC  were  given  intravenously together with Brucella 
and lymphoid cells; for the second stimulation both antigens were given intraperitoneally 4 
days later. Bleeding was carried out 4 days after the second stimulation. Each dot represents 
14-24 recipients.  SPL  =  spleen cells, THY  =  thymus cells, BU  =  bursa cells, BM  =  bone 
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trary  to  the  findings with  SRBC  antibodies,  anti-Brucella  response  by bursa 
cells does not significantly decline at 17 wk of age. These observations indicate 
a different distribution  of immunocompetent cells for anti-SRBC response and 
for anti-Brucella  response. 
With a  dose of 2  X  107 lymphoid cells, no antibody response was obtained 
with cells from newly hatched and 4-day old donors (Figs.  1 and 2). Therefore, 
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Fro.  2.  Antibody  response to Brucella  aborlus  by 2  X  107 lymphoid cells injected  into 
cyclophosphamide-treated 4-day old chicks. Titrations  were clone from the same samples as 
those presented in Fig. 1. 
4- and  ll-day cells were also used in  a  4  X  107 dose  (Table III). The results 
with cells from 11-day old donors confirm those obtained with  the smaller cell 
dose: to SRBC the best responses were given by spleen  and  thymus ceils,  and 
to Brucella  by bursa  and spleen  cells.  With  cells from 4-day old donors,  only 
spleen  cells  induced  a  response  to SRBC; neither  bone marrow,  thymus,  nor 
spleen  cells responded  to Brucella.  With 4  day bursa,  a  debris-free suspension 
for an intravenous injection was not achieved with a sufficiently high (4 X  107) 
concentration of bursa cells; therefore, no data are presented. PAAVO  TOIVANEN,  AULI  TOIVANEN,  AND  ROBERT  A.  GOOD  823 
Antibody production by cells taken from yolk sac and embryonic liver was 
also studied. A similar schedule for cell transfer and antigenic stimulation was 
employed as in studies with bursa, bone marrow, spleen, and thymus cells. Yolk 
sac or liver preparations did not induce antibody response to SRBC or Brucella 
(Table IV). 
TABLE  III 
Antibody  Response  by 4  ×  10  7 Lymphoid  Cells Injected  into  Cyclophosphamide-Trealed  4-Day 
Old Chickens 
Cells transferred 
SRBC 
No.  of  Mean :t: Sl~ logo. titer of responders 
responders/ 
total  Direct  Indirect 
Brucella 
No. of  Mean ±  so log2 
responders/  titer of 
total  responders 
4 day bone marrow  0/19  --  --  0/19 
4 day thymus  0/17  --  --  0/17 
4 day spleen  4/13  0.2  4- 0.5  2.2  4- 0.5  0/13 
11 day bone marrow  1/17  --  1.0  1/17  3.0 
11 day thymus  4/17  1.0  -4-  1.0  2.8  -4-  1.5  2/17  4.0  4- 0.0 
11 day bursa  1/14  --  4.0  7/14  3.1  4-4- 0.7 
11 day spleen  8/19  1.0  ±  0.8  3.0  4-  1.7  6/19  4.5  4- 0.6 
Both  antigens were given intravenously  together with the cells, and again 4 days later 
intraperitoneally. Bleeding was carried out 4 days after the second stimulation. 
TABLE IV 
Summary  of Experiments  Revealing  No  Antibody  Response  to  SRBC  and  Brucella  by  Cells 
Transferred  to Cyclophosphamide-Treated  4-Day Old Chicks 
Cells transferred  >( 10 7  No. of recipients 
7 day yolk sac  1  13 
I1 day  "  "  4  7 
11 day embryonic liver  1  13 
14 day  "  "  1  14 
Both  antigens were given intravenously  together with  the cells, and again 4 days later 
intraperitoneally. Bleeding was carried out 4 days after the second stimulation. 
Cellular Cooperation.--During  ontogeny, spleen cells were the first to produce 
antibodies to SRBC  (Fig. 1, Table III). The spleen is considered a  peripheral 
lymphoid organ receiving its immunocompetent lymphoid cell population from 
thymus and bursa. The early vigorous response to SlZBC by spleen cells may 
indicate a cellular cooperation by different cell types, similarly to that observed 
with thymus and bone marrow in mice and less clearly in other rodents (25-27, 
35,  36). Consideration of a synergistic action is also provoked by the vigorous 
anti-SRBC response by 4-day old normal intact birds (Table I), when corn- 824  IMMUNOCOMPETENT  CELL  FOR  HUMORAL  IMMUNITY 
pared with the minimal responses produced by 4-day spleen cells in the transfer 
studies (Fig. 1, Table III). Yet we repeatedly found that the spleen at 4  days 
contained less than 2 X  107 cells, which was  the usual number of cells trans- 
ferred per chick. 
To study possible synergistic influences of thymus  and bone marrow cells, 
2  X  107 lymphoid cells from each organ were injected intravenously together 
with 0.1  ml of packed SRBC into 4-day old cyclophosphamide-treated recipi- 
ents. Otherwise, the same scheme as was employed for antibody production by 
cells from a single organ was followed. This protocol includes an intraperitoneal 
stimulation 4 days after the initial injection, and a bleeding after an additional 
4 days. The controls received 4  X  10  r thymus or bone marrow cells with the 
antigen. Each group consisted of 9-17 cell recipients. Neither direct or indirect 
antibody titer assays obtained revealed evidence for synergism between thymus 
and bone marrow cells. Equally negative results were obtained using donors of 
different ages,  as well as using a  smaller dose of the antigen (0.1  ml of 20% 
SRBC). Altogether, 4- and 11-day, 3-, 6-, 9-, and 15-wk old donors were sepa- 
rately used in these experiments. 
Using a similar experimental design, attempts were made to demonstrate syn- 
ergism between thymus and bursa cells in antibody response to SRBC. 11-day 
and 3- and 6-wk old cell donors were used. None of the experiments revealed 
any sign of cellular cooperation between thymus and bursa cells. 
DISCUSSION 
It  has  been  previously reported  that  cyclophosphamide treatment  in  the 
newly hatched period leads in chicken to a severe and permanent deficiency in 
humoral immunity (1,  2,  2941). Our data indicate that cellular immunity is 
also affected. The presence of an intact cellular immunity in chickens treated in 
the newly hatched period with cyclophosphamide would be indeed surprising, 
because normally thymus cells, like bursa cells, are proliferating vigorously dur- 
ing this period. Also, 30 % of hormonally bursectomized chickens show varying 
degrees of thymic atrophy (37). Seto (34)  has demonstrated that treatment of 
chick embryos with cyclophosphamide on the  17th or 18th day of incubation 
reduces the posthatching graft-vs.-host competence of lymphoid cells; the influ- 
ence of cyclophosphamide on graft-vs.-host activity was considerable up to the 
age of 6 wk and could still be detected at 11 wk. A similar effect is reflected in 
the study of Lerman and Weidanz (29). These investigators measured graft-vs.- 
host activity of peripheral blood from chickens treated in the newly hatched 
period with  cyclophosphamide. Calculation of their data  reveals a  difference 
between  the  cyclophosphamide-treated donors  and  normal  untreated  donors 
(P <  0.025, Student's t test). Further, at the time of the test (at 8 wk of ages) 
less than 30% of the original group were alive; these chickens probably repre- 
sented the population least  thymic deficient. When  evaluating graft-vs.-host 
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strong reactions which may mask differences detectable only if smaller number 
of cells are employed. This hazard was  clearly shown in our experiments in 
which 21-day old donors were used (Table II). 
For the purpose of the present study, the profound dual immunoincompe- 
tence of  cyclophosphamide-treated chicks makes  them  especially suitable  as 
cell recipients. Indeed they serve as the equivalent of living test tubes having 
little background immunity of their own during  the  test period. When  this 
model is used with chicks isogeneic at the major histocompatibility locus, both 
cell rejection by the host  and  graft-vs.-host reaction which has  complicated 
many of the earlier studies (6-17) can be avoided. 
Using this model, a systematic study of the ontogeny of immunocompetent 
cells in different chicken tissues has been possible. Our results show that during 
ontogeny, immunocompetent cells appear first in the spleen with respect to an 
anti-SRBC  response.  For anti-Brucella  response,  immunocompetent cells are 
found in significant numbers first in the bursa.  Bursa cells  are quite poor in 
their anti-SRBC response; this is the only immune response by any of the  cell 
types studied where the response decreases with increasing age of donors. At 
17  wk,  when  bursa  is  not  more  than  a  rudiment,  bursa  cells  do  not  form 
antibodies against SRBC, but their response to Brucella is nearly as  vigorous 
as it was at 7 wk of age. Our findings together with prior studies (23, 24,  38, 
39) indicate that Brucella  and some other bacterial antigens are to be consid- 
ered as bursa-dependent or thymus-independent antigens. 
Gilmour et al. (23), using irradiated chicks as recipients of cells isogeneic at 
the B  locus, could not demonstrate anti-SRBC response by transferred bursa 
cells. Their approach was different from ours in that the cells were given intra- 
peritoneally and stimulated only once, immediately after  the  transfer.  How- 
ever, if the stimulation of 2 X  108 10-wk bursa cells was delayed by 5 days and 
bleeding done 7 days thereafter, 8 of ll  recipients responded with low titers 
(23). This and the observations herein suggest that the anti-SRBC response by 
bursa cells  may not be due to the presence of immunocompetent cells in the 
bursa, but rather to the development of immunocompetent cells from their pro- 
genitors, i.e., from the bursal stem cells or their immediate descendants. The 
curves showing the anti-SRBC response by bursa cells (Fig. 1) reflect quite ac- 
curately previously described maturational  events and  the  presence of stem 
cells in the bursa (2). By contrast, the corresponding curves for spleen, thymus, 
and bone marrow, and also for bursa in anti-Brucella  response (Fig. 2) are quite 
different. We conclude that the bursa of Fabricius does not contain immuno- 
competent cells  for the  anti-SRBC  response, whereas respective cells  for the 
production of Brucella antibodies are present in the bursa in significant numbers 
beginning as early as the 2nd wk after hatching. 
According to our data, the chicken thymus contains ceils capable of respond- 
ing to SRBC and to Brucella. This is contrary to that inferred from studies of 
mammalian thymus when unimmunized donors are used (25  27, 35, 36), and 826  IMMUNOCOMPF.TENT  CELL  FOR  HUMORAL  IMMUNITY 
reveals again the complex cellular composition of the avian thymus. As previ- 
mlslv discussed (2), the literature documents that cells of bursal origin are found 
in the chicken thymus (40-44). However, these reports do not give any sugges- 
tions about the functional cell types present. Findings in the present study indi- 
cate that immunocompetent ceils responsible for humoral antibody production 
are present in  the chicken thymus. These cells probably represent the bursa- 
derived population in the thymus. 
It has become generally accepted that a cooperation between thynms-derived 
and bone marrow-derived cells occurs in the antibody response to SRBC  and 
some other thymus-dependent antigens (25  27, 35, 36). We also considered that 
a cellular cooperation might explain the early occurrence of immunocompetent 
cells in the chicken spleen. However, none of our efforts to establish the exist- 
ence of synergism between cell types were successful even though  we studied 
both thy~nus-marrow and  thymus-bursa combinations.  Using  a  model similar 
to that employed here, Jeejeebhoy (36)  demonstrated in mice a synergism be- 
tween  thymus and marrow cells in  the production of SRBC  agglutinins;  thus 
our failure probably is not attributable to the model used. Experience of Thor- 
becke and coworkers (23, 45) with the response to SRBC of thymus-bursa com- 
binations in irradiated chicks agrees with ours. Recently, McArthur et al. (46) 
have  been  able  to  demonstrate  a  thymus-marrow  synergism  in  response  of 
chicken cells to SRBC. For a  cooperative effect, bone marrow cells  had  to  be 
used in numerical excess over the thymus cells.  It seems likely to us, that cel- 
lular  cooperation is not  absolutely necessary for a  normal  antibody response 
and may only be active in exceptional situations  (46-.52). 
A  general scheme for the ontogeny of the bursa-dependent immune system 
is shown in Table V on the basis of the observations presented in this and two 
of our papers published elsewhere (1, 2). It is clear that stem cells and immuno- 
competent ceils have different distributions.  The stern  ceils,  characterized by 
their  ability  to  confer  a  long-term reconstitution  of iramunodeficient  chicks, 
are found in the bursa during  embryonic development and during the 1st few 
wk after hatching. The stem cells appear in bone marrow, thymus, and spleen 
only after the bursa has begun to involute. Furthermore, the early bursal stem 
cell  and that occurring later in both  the bursa and the other organs differ in 
one important feature: only the embrvonic or early bursal stem cell is able to, 
and must, enter the bursa and proliferate in the bursal follicles. By 3  4 wk of 
age a  shift in  the degree of maturation of the bursal stem cell  population oc- 
curs. After this age stem cells of the bursa-dependent line can proceed to their 
ultimate destination and develop without local bursal influence. Perhaps they 
already carry membrane markers (53--56) reflecting a differentiative step which 
restricts their traffic pattern. The negative results obtained with yolk sac and 
fetal liver cells indicate that the bursal reticulum of 4-day old chicks does not 
any more possess  the  essential  environment for maturation  of the  primitive 
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seems to proceed stepwise from the very first multipotential stem cell.  Each 
succeeding phase can only be entered when the preceding is completed. 
The first immunocompetent cells for humoral immunity were encountered in 
the spleen at the age of 4 days. After the age of 3 wk these cells were present 
in increasing numbers in all the organs studied,  the only exception being the 
TABLE V 
Comparison of Short-term and  Long-term Ejects of Different  Cell Transplantations  to 4-Day 
Old  Cyclophosphamide-Treated Chickens 
Cells transferred 
Short-term  effects  Long-term  effects 
Antibody  response  Antibody  response  Natural  Microscopic 
to  to  rabbit  Immuno-  structure  Sur-  Body 
hemag-  globulins  vival  weight 
SRBC  Brucella  SRBC  Brucella  glutinins  Spleen Bursa 
17-21 day  embryonic  --*  --  ++  +  +  ++  ++  ++  ++  + 
bursa 
4  day bursa  --  --  +++:~  ++  ++  ++  ++  ++  ++  + 
3~  wk bursa  +  ++  +  --  +++  ++\  --  +  -- 
7-t0 wk bursa  +  +++  +++  +++  +++  +++/  +  -  +  - 
16-17 wk bursa  --  +++  --  -- 
14-20 day  embryonic  ........ 
bone  marrow 
4dayb  ....  arrow  --  ......  _  --}  --  -- 
3}~ wk bone  marrow  +  +  --  --  --  ++  --  +  + 
7  wk bone  marrow  +  +  -  -  ++  ++  -  + 
10-17 wk bone  +++  +++  +++  +++  +++  +++  +  -  ++  ++ 
marrow 
4  day  thymus  .......... 
31/~ wk thymus  +  +  --  --  --  +  .... 
7  wk thymus  ++  +  --  --  ++  ++  --  --  +  + 
14-17 wk thymus  +++  +++  +  +  ++Jr-  ++  +  --  ++  ++ 
14  21 day  embryonic  .......... 
spleen 
4  day  spleen  +  ......... 
3~,~ wk spleen  +++  +  --  --  --  ++  --  --  +  + 
14-17 wk spleen  +++  +++  +++  +++  +++  +++  +  --  ++  ++ 
In the text,  short-term  effects are considered  a  function  of immunocompetent  cells, and  long-term  effects a  function 
of stem  cells. 
*  --:  Denotes  no  restoration;  indistinguishable  from  chickens  treated  with cyclophosphamide  alone. 
:~ +++:  Denotes  in long-term effects restoration  of the function  or structure to the level of normal,  untreated  con- 
trols;  in short-term  effects the maximal  antibody  production. 
bursa cells involved in the anti-SRB C response. In the bursa the stem cell popula- 
tion is present before immunocompetent cells can be detected. The opposite is 
true for bone marrow, spleen, and thymus where cells capable of providing short- 
term antibody-forming capacity are always found some weeks before capacity to 
achieve a  long-term reconstitution of immunodeficient chicks. These  findings 
indicate that all along its postembryonic development bursa seeds out immuno- 
competent cells but does not release the lymphoid stem cell population before 
this population has matured to a  new level and before the bursa itself, after 
fulfilling its task, begins to involute. 828  IMMUNOCOMPETENT CELL  FOR  HUI~ORAL IMMUNITY 
SUMMARY 
To study the occurrence of immunocompetent cells directly responsible for 
antibody production,  cells from yolk sac, embryonic liver, bursa of Fabricius, 
bone marrow, spleen, or thymus were injected together with SRB C and Brucella 
aborlus into 4-day old cyclophosphamide-treated chicks. A second stimulation 
was given 4 days later, and samples taken 4 days thereafter were used for anti- 
body titrations. 
During  ontogeny,  immunocompetent cells  appeared  in  significant numbers 
first in the spleen for anti-SRBC responses, but in the bursa for anti-Brucella 
responses. Later these  cells were also found in  thymus and  bone marrow. In 
the bursa,  cells immunocompetent for anti-SRBC  response were not  encoun- 
tered in significant numbers. The slight response to SRBC by transferred bursa 
cells reflects the presence of stem cells and their immediate descendents in the 
bursa at different stages of development. 
These findings are compared with  the development and maturation  of the 
stem cell responsible for humoral immunity. In the bursa, development of the 
stem cell population precedes that of immunocompetent cells. The opposite re- 
lationship was found in bone marrow, spleen, and thymus where immunocom- 
petent cells were always present some weeks before the appearance of cells ca- 
pable of achieving a  long-lasting reconstitution  of bursa-dependent functions. 
These observations reveal that the bursa seeds out immunocompetent cells dur- 
ing its entire postembryonic development, but does not release the lymphoid 
stem cell population before this population has matured sufficiently and before 
the bursa itself, after fulfilling its function, starts to involute. 
Fertilized eggs of B2B 2 and B2B 1~ lines were kindly supplied by Dr.  G. R. J. Law, Basic 
Research Laboratories of the Hy-Line Poultry Farms (Johnston, Iowa). We also thank Mrs. 
Leyla Sarquis for technical assistance, Mrs. Seija Murto and Miss Hilkka Sollo for statistical 
calculations, and Dr. Toni Mariani for criticism of the manuscript. 
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